One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Sheldon, MD
Miami Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Simbec Research Limited
Merthyr Tydfil, United Kingdom
- Accelovance
Huntsville, Alabama, United States
- Accelovance
Washington D.C., District of Columbia, United States
- Florida Medical Research Institute
Gainesville, Florida, United States
- Accelovance
Melbourne, Florida, United States
- Miami Research Associates
Miami, Florida, United States
- Radiant Research
Pinellas Park, Florida, United States
- Accelovance
South Bend, Indiana, United States
- Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
- Accelovance
Amarillo, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2005
- Primary completion
- 30 Apr 2007
- Completion
- 30 Apr 2007
- Last update posted
- 15 Sept 2008
- Registered enrollment
- 123
- Registry id
- NCT00246467
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.